The Prevalence of Hearing Loss Among Children With Congenital Hypothyroidism
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Congenital hypothyroidism (CH) occurs in 1:4000 live births. Neurological disturbances like speech delay, motor delay and lower IQ were reported in children with CH. Evidence from animal experiments indicate that CH is associated with high frequency of deafness. Morphological changes of the external and internal cholera hairs were reported in mutagenic mice with CH. Anatomical changes of the internal ear and low hearing threshold were reported in mice bearing Dual oxidase 2 (Duox2) gene mutations, which is responsible of oxidation of iodide. Knockout of Pax8 gene in mice resulted in both agenesis of thyroid gland and deafness. Early L-thyroxin therapy prevented the development of deafness in those mice. The expression of thyroid receptor α (TRα) in the external and internal cholera hairs in mice indicates that the thyroid hormones have an important role in the development of the internal ear.
The etiology of deafness in human is both genetic and environmental. The prevalence of deafness in live births is 1:1000 and among them 60% is genetic. Connexin 26 gene mutations are the most common cause of inherited deafness and account for about 40% of the genetic cases. In two conditions in human the coexistence of hypothyroidism and deafness were reported; Pendred syndrome and thyroid hormone resistance syndrome.
The prevalence of hearing loss in human with CH was explored in only few studies and the results are contrary.
The aim of the current study is to study the prevalence of hearing loss among children with CH and to compare the clinical, biochemical and genetic characteristics between subjects with hearing loss to those without hearing loss.
| Condition | Intervention |
|---|---|
|
Congenital Hypothyroidism Hearing Loss |
Other: Audiometry |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
- Hearing Level [ Time Frame: 2 years ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 200 |
| Study Start Date: | September 2010 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Congenital hypothyroidism
Patient which were diagnosed with congenital hypothyroidism
|
Other: Audiometry
Audiometry
|
|
Controls
Patients without any endocrine or hearing problems
|
Other: Audiometry
Audiometry
|
Eligibility| Ages Eligible for Study: | 2 Years to 30 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Patients aged 2-30 years with congenital hypothyroidism which are being followed at the Pediatric Endocrine Department at Ha'Emek Medical Center.
Inclusion Criteria:
- Patients with congenital hypothyroidism aged 2-30 years
Exclusion Criteria:
- Hearing defects in the family
- Intrauterine infections
- Perinatal hypoxia
- Long term therapy with aminoglycosides
- Acoustic trauma in the past
Contacts and Locations| Contact: Yardena Rakover - Tenenbaum, M.D. | 972-4-6494116 | rakover_y@clalit.org.il |
| Contact: Nirit Vardi, M.A. | 972-4-6495368 | nirit_va@clalit.org.il |
| Israel | |
| Ha'Emek Medical Center | Not yet recruiting |
| Afula, Israel, 18101 | |
| Contact: Yardena Rakover - Tenenbaum, M.D. 972-4-6495203 rakover_y@clalit.org.il | |
| Principal Investigator: Yardena Rakover - Tenenbaum, M.D. | |
| Ha'Emek Medical Center | Recruiting |
| Afula, Israel, 18101 | |
| Contact: Nirit Vardi, MsC 97246495368 nirit_va@clalit.org.il | |
| Principal Investigator: Yardena T Rakover, MD | |
More Information
No publications provided
| Responsible Party: | Dr. Yardena Tenenbaum - Rakover, HaEmek Medical Center, Israel |
| ClinicalTrials.gov Identifier: | NCT01223638 History of Changes |
| Other Study ID Numbers: | 0128-08-EMC |
| Study First Received: | October 3, 2010 |
| Last Updated: | October 18, 2010 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
Keywords provided by HaEmek Medical Center, Israel:
|
Congenital hypothyroidism(CH) Hearing loss among children with CH |
Additional relevant MeSH terms:
|
Congenital Hypothyroidism Hearing Loss Deafness Hypothyroidism Dwarfism Bone Diseases, Developmental Bone Diseases Musculoskeletal Diseases Bone Diseases, Endocrine Genetic Diseases, Inborn |
Endocrine System Diseases Thyroid Diseases Hearing Disorders Ear Diseases Otorhinolaryngologic Diseases Sensation Disorders Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on May 16, 2013